Measles is back in the United States. More than 1,500 cases have already been reported in 2026, putting the country on pace to surpass last year’s total of more than 2,200, the highest in decades. Public health officials warn the nation’s status as “measles free” is now at risk as childhood vaccination rates decline.
Measles may not be the only disease poised for a comeback. Another virus that once infected thousands of American children each year could be heading in the same direction.
A recent study my colleagues and I conducted found that hepatitis B vaccination rates among newborns declined by more than 10% between 2023 and August 2025.
Before routine vaccination began, hepatitis B infected roughly 18,000 children under the age of 10 in the United States every year. About half of those infections were passed from mother to child during birth. The rest occurred through everyday exposure, often through contact with a caregiver or family member who did not know they were infected.
The consequences can be lifelong. As many as 90% of babies infected in their first year of life develop chronic hepatitis B. Over time, chronic infection can lead to cirrhosis, liver cancer and liver failure.
